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During the past 10 years, several Pex genes have been knocked out in the mouse with the purpose to generate models to study the pathogenesis
of peroxisome biogenesis disorders and/or to investigate the physiological importance of the Pex proteins. More recently, mice with selective
inactivation of a Pex gene in particular cell types were created. The metabolic abnormalities in peroxisome deficient mice paralleled to a large
extent those of Zellweger patients. Several but not all of the clinical and histological features reported in patients also occurred in peroxisome
deficient mice as for example hypotonia, cortical and cerebellar malformations, endochondral ossification defects, hepatomegaly, liver fibrosis and
ultrastructural abnormalities of mitochondria in hepatocytes. Although the molecular origins of the observed pathologies have not yet been
resolved, several new insights on the importance of peroxisomes in different tissues have emerged.
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The metabolic role of peroxisomes has been extensively
studied during the last 30 years mostly by using the rat liver as a
source of peroxisomes [1]. The identification of human diseases
that are due to peroxisomal dysfunction underscored the
physiological importance of peroxisomal metabolism in differ-
ent tissues. However, the molecular mechanisms leading to
anomalies such as neuronal migration defects, hypotonia, dys-
and demyelination, kidney, eye and testicular defects, abnor-
malities in bone development and facial dysmorphism remain
unresolved. Since naturally occurring peroxisomal disease mo-
dels are lacking, it was necessary to generate such models by
gene manipulation to study the pathogenesis of these diseases.
The newly discovered Pex genes and the novel insights in theAbbreviations: Acox1, acyl-CoA oxidase 1; ALD, adrenoleukodystrophy;
DHAPAT, dihydroxyacetonephosphate acyltransferase; DHAP, dihydroxyace-
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NMDA, N-methyl-D-aspartate; PTS, peroxisome targeting signal; PUFA,
polyunsaturated fatty acid; SCP, sterol carrier protein; VLCFA, very long
chain fatty acid
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unique opportunity to apply gene targeting techniques. De-
pending on the mutated gene, mice were created in which
either PTS1- and PTS2-dependent protein import (Pex5, Pex2,
Pex13), or only PTS2-dependent import (Pex7), or peroxisome
proliferation (Pex11) were affected. More recently, mice with
conditional inactivation of peroxisome biogenesis in specific
cell types became available i.e. mice with selective inactivation
in hepatocytes and in Sertoli cells.
2. Generalised inactivation of Pex genes involved in
PTS1- and PTS2-dependent protein import: models for
Zellweger syndrome?
2.1. Phenotype of the mice
Three different Pex genes were inactivated in the mouse i.e.
Pex5, Pex2 and Pex13 [2–4]. In view of the complete block of
PTS1- and PTS2-dependent matrix enzyme import in each case,
the three knockout lines were expected to constitute a model for
Zellweger syndrome, the most severe peroxisome biogenesis
disorder [5]. All knockout mice displayed severe hypotonia and
growth retardation at birth and they died within a few days. A
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specific genetic background i.e. Swiss Webster×129Sv Ev a
fraction of which was less hypotonic and survived 1, 2 or rarely 3
weeks [6]. As discussed below, all knockout strains displayed
abnormalities in the formation of the brain. However, other
typical hallmarks present in fetal Zellweger patients were not
found, including renal cysts and facial dysmorphism. At birth the
mice did not display major liver pathology, a feature that only
develops in the postnatal period in patients.
At the subcellular level, embryonic fibroblast cultures de-
rived from Pex5, Pex2 and Pex13 knockout mice contained
peroxisomal remnants which were reduced in number but
increased in size as compared to regular peroxisomes [2–4]. This
is very similar to findings in Zellweger patient fibroblasts.
Recently, it was demonstrated that in cultured Pex13 null mouse
fibroblasts (like in Pex1 deficient human fibroblasts), remnant
peroxisomes displayed an altered distribution as compared to
normal peroxisomes in wild type fibroblasts (Fig. 1A, B) [7].
The peroxisomal ghosts were only present in the cell centre but
not in the periphery [7]. However, the peroxisomal ghosts were
still associated with microtubuli, as previously shown for normal
peroxisomes in different cell lines like HepG2 and Cos cells [8].
Likewise, in cultured Pex13 null neurons and astrocytes
peroxisomes were clustered in the cell soma.
Ultrastructural examination of the liver of the three Pex
knockout models revealed severe abnormalities of the mito-
chondria in hepatocytes, in particular at the level of the inner
mitochondrial membrane [2,4,9,10] (see also 5.1). Such
mitochondrial anomalies in hepatocytes were also described in
some early papers on Zellweger patients [11–13].
Overall, it can be concluded that several but not all features of
human Zellweger patients are mimicked in the mouse models.
This might be related to the shorter timeframe of murine as
compared to human fetal development. It is in fact quite remark-
able that within the short period in which the mouse brain is
formed, the absence of functional peroxisomes has such an
important impact, as will be further discussed below.
2.2. Metabolic changes
Most of the major metabolic changes observed in Zellweger
patients were recapitulated in the mouse models. An important
advantage of the latter models is that metabolite levels can be
measured not only in body fluids but also in the diseased tissues
at several stages. It was striking that C26:0 was already 2-fold
increased at E16.5 in Pex5 knockout mouse brain and liver
indicating that peroxisomal β-oxidation was already active at
this stage in wildtype mice [14]. In newborn Pex knockout mice,
this very long chain fatty acid (VLCFA) was about 10-foldFig. 1. Pathology in generalised Pex knockout mice. (A–B) Immunofluorescent
peroxisomal membranes in cultured fibroblasts. In wild type fibroblasts (A) peroxis
fibroblasts (B) peroxisomes are clustered in the cell centre but still aligned with micro
wild type (C) and Pex5−/− mice (D) reveals increased cell densities in the intermedi
GZ=germinative zone. (E–F) Immunofluorescent staining of Purkinje cells in the cer
D28K antibody. In the knockout, these cells remain polydendritic and the size of the d
mount skeletal staining of cartilage (blue) and bone (red) of newborn wild type (G
hindpaws of the knockout is visible (arrows). Reprinted from [7,2,6,29] with permiincreased in plasma (Pex2) [3]) in liver and brain tissue lipids
(Pex13) [4] and in liver and brain phospholipids (Pex5) [2].
More detailed investigations documented that C26:0 was also
10-fold increased in brain sphingolipids (ceramide and sphin-
gomyelin) in Pex5 knockout mice [15]. The concentration of the
polyunsaturated fatty acid, docosahexaenoic acid (DHA) which
depends on peroxisomal β-oxidation for its synthesis was
reduced by 30% in newborn Pex5 knockout mice [16]. The
branched chain fatty acids, phytanic and pristanic acid, and bile
acids have thus far not been measured in newborn Pex knockout
mice. Plasmalogens, a subclass of ether phospholipids, were
20- to 100-fold reduced in liver and brain (Pex5, Pex13) and
erythrocytes (Pex2) of newborn mice due to the inactivity of
the peroxisomal enzymes DHAPAT and alkyl DHAP synthase.
Newborn Pex5 knockout mice contained normal levels of
cholesterol in plasma, liver and brain [17] and the activity of
cholesterol synthesizing enzymes was either normal or slightly
increased [18]. This is not consistent with the 40% reduction of
plasma cholesterol described in newborn Pex2 knockout mice
[10]. In 10-day-old Pex2 knockout mice, cholesterol levels of
plasma and liver were also 40% reduced but they were normal in
brain and other tissues. The reduced cholesterol levels were
accompanied by a concerted increase in expression and activity
of cholesterol synthesizing enzymes in liver homogenates
probably mediated by the induction of SREBP2. Because it is
well known that the brain is self sufficient with regard to
cholesterol synthesis, the normal cholesterol content in brain of
Pex5 and Pex2 knockout mice strongly suggests that the absence
of import competent peroxisomes has no direct negative effects
on the cholesterogenesis. The aberrant cholesterol homeostasis
in liver of Pex2 knockout mice might be a consequence of the
metabolic perturbations that occur in the liver as exemplified by
the development of steatosis and cholestasis [10].
2.3. Cortical neuronal migration
The disturbed lamination of the cortical plate associated with
medial pachygyria and lateral polymicrogyria is a major charac-
teristic of Zellweger patients [19–21]. It is ascribed to a unique
defect of the neuronal migration process that is clearly
distinguishable from other migration disorders such as those
seen in lissencephaly or double cortex syndrome. In all three Pex
knockout models an altered distribution of cortical neurons was
observed [2–4] (Fig. 1C, D). For Pex5 and Pex2 knockout mice,
a migration disorder was demonstrated by performing 5′,3′-
bromo-2′-deoxyuridine (BrdU) birthdating experiments. Fur-
thermore, a delay in the differentiation of neurons, increased
apoptotic cell death but a normal distribution of radial glial cells
were reported for Pex5 knockout pups.staining of α-tubulin (red) and Pex14p (green) to visualise microtubuli and
omes are associated with microtubuli throughout the cell whereas in Pex13−/−
tubuli. (C–D) Cresyl violet staining of frontal sections of the cortex of newborn
ate zone (IZ) of the knockout, the prospective white matter. CP=cortical plate,
ebellum of 7-day-old wild type (E) and Pex2−/−mice (F) using the anti-calbindin
endritic arbor and the degree of branching are markedly reduced. (G–H) Whole
) and Pex7−/− pups (H). A lack of ossification in the middle phalanges of the
ssion from the respective publishers.
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increased levels of VLCFA could play a causative role in these
defects. Supplementation of pregnant dams with DHA normal-
ised the levels of this PUFA in brain but did neither improve
hypotonia, nor the migration disorder [16]. In mice with a
selective defect of peroxisomal β-oxidation by inactivating
multifunctional protein 2 (MFP-2), levels of C26:0 were in-
creased to the same extent as in Pex5 knockout mice but no
migration defect could be observed [22]. This is at variance with
the human situation where MFP-2 deficiency is often associated
with brain malformations which are very similar to those present
in Zellweger syndrome [23]. These observations rule out that
alterations in fatty acid levels on their own induce cytoarchitec-
tonic abnormalities in mouse brain.
The possible involvement of glutamatergic neurotransmis-
sion via the NMDA receptor, known to control the speed of
migration was also examined [24]. Treatment of Pex5−/−
embryos with NMDA antagonists induced embryonic death
whereas NMDA agonists partially reversed the migration defect
[25]. A deficit in NMDA signal transduction was demonstrated
in neuronal cultures derived from Pex5 knockout mice by
monitoring calcium influx in response to NMDA. Pex5−/− cells
were less sensitive to NMDA than wild type cells but sensitivity
could be restored by preincubation with the ether phospholipid
platelet activating factor (PAF) [25]. Attempts to prove that the
concentration of PAF is reduced in brain of Pex5−/−mice did not
succeed probably due to the very low levels and instability of
PAF but the content of the degradation product lysoPAF was
3-fold reduced (H. Van Overloop, M. Baes and P. Van
Veldhoven, unpublished observations). Although PAF is a well
known regulator of neuronal migration [24] and thus a very good
candidate to link peroxisome deficiency to migration, the
absence of clearcut cortical migration defects in Rhizomelic
Chondrodysplasia Punctata (RCDP) patients, who have a
selective and severe deficiency of ether lipids, contradicts such
a primary role of PAF. To further document a potential involve-
ment of PAF in the neuronal migration defect associated with
peroxisome deficiency, it will be of importance to investigate
cortical lamination in DHAPAT knockout mice [26], a model
with a selective depletion of ether lipids.
A major question is whether the brain malformations of
peroxisome deficient mice are caused by the local absence of
peroxisomes in the brain or by extraneural deletion of peroxi-
somal metabolic activity. Pex5−/− mice with a selective recon-
stitution of peroxisomal function in brain or in liver both
exhibited a significant correction of the neuronal migration
defect despite an incomplete reconstitution of peroxisomal
function in the targeted tissue [27]. These data suggest that
peroxisomal metabolism in brain but also in extraneural tissues
is necessary for the normal development of the mouse neocortex.
Interestingly, despite the improvements of the neuronal
migration, both Pex5 rescue models were as hypotonic as the
generalised Pex5 knockout mice and died on the day of birth.
Overall, these investigations with the Pex knockout mouse
models were important to prove that peroxisome deficiency leads
to cortical malformations in another species besides humans. A
number of metabolites were excluded as single causative factorsbut there is still no clear view on the molecular mechanism
underlying the migration defect.
2.4. Formation of cerebellum
In contrast to the cortex, the formation of the cerebellum
extends into the postnatal period of the mouse. Therefore, the
early death of Pex5 and Pex13 knockout mice precluded the
analysis of cerebellar development but the longer survival of
some Pex2 knockout mice allowed an extensive analysis of
cerebellar histogenesis [6]. Abnormalities were reported at the
level of granule cells with slower migration from the external
granular layer (EGL) to the internal granular layer (IGL) and
increased cell death in the EGL. These migratory abnormalities
in the postnatally developing cerebellum were more severe than
those seen in the prenatally developing cortex [6]. This was
attributed to postnatal malnutrition problems, increasing hepatic
or renal dysfunction after birth and/or to the fact that maternal
metabolism could clear toxic substances from the embryonic
circulation [6]. The majority of Purkinje cells aligned under the
cerebellar surface and only rare cells mislocalised in the IGL
which is very different from the extensive Purkinje cell hetero-
topias in human Zellweger patients [19,20]. However, the
Purkinje cells displayed stunted dendritic trees with abnormal
arborization (Fig. 1E, F). A delayed maturation of the olivary
climbing fibers and their defective translocation from the
perisomatic to the dendritic compartment of Purkinje cells re-
sulted in numerous spines on the soma and dendrites of Purkinje
cells. Preliminary studies by Faust et al. with mixed cerebellar
cultures further suggested that the abnormal maturation of
Purkinje cells might be due to the inactivity of intrinsic pero-
xisomal metabolism as well as to the elimination of hepatic
peroxisomal metabolism [28]. Indeed, also in cultured Pex2
knockout Purkinje cells a deficient branching was observed
whereas on the other hand, supplementation of pups with mature
bile acids not only improved survival of the mice but also
arborization of Purkinje cells.
3. Inactivation of Pex7 involved in PTS-2 dependent
protein import: a model for RCDP type 1?
In mammals, the task of Pex7p is restricted to the import
of a few PTS2 containing proteins. Thus far only alkyl
DHAPsynthase, phytanoyl CoA hydroxylase and 3-oxoacyl-
CoA thiolase were unequivocally shown to possess such a
signal but they take part in three major peroxisomal pathways
i.e. ether phospholipid synthesis, α-oxidation and β-oxidation,
respectively.
In Pex7 knockout mice [29] the inactivity of mislocalised
alkyl DHAP synthase causes the expected depletion of plasma-
logens in brain and erythrocytes. Due to the mislocalisation of
phytanoyl-CoA hydroxylase a slight accumulation of phytanic
acid was seen in newborn mice. Supplementation of adult Pex7
knockout mice with phytol triggered a massive increase in
plasma and tissue levels of this branched chain fatty acid. Based
on data of RCDP type 1 patients in which straight chain pero-
xisomal β-oxidation substrates are not accumulating [5,30],
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SCPx, it was surprising to find that C26:0 levels were elevated in
plasma and tissues of newborn Pex7 knockout mice.
Given this impaired functioning of all major peroxisomal
pathways, it is not surprising that the phenotype of Pex7 knock-
out mice is very similar to that of Pex5 knockout mice although
the penetrance is very variable [29]. About 50% of the Pex7
knockout mice were very hypotonic at birth and died postnatally,
20% died before weaning and the others survived past 18
months. All knockout mice displayed a neuronal migration
defect that was less severe than in Pex5 knockout mice. At birth
several cartilage based structures that depend on endochondral
ossification for their formation were not ossified or showed a
marked delay in ossification e.g. distal bone elements of the
limbs, parts of the skull and the vertebrae (Fig. 1G, H) [29].
Since abnormalities in bone formation are a major hallmark
of RCDP patients, this mouse model should allow for the further
investigation of the precise role of peroxisomes in the ossifi-
cation process. Other features observed in Pex7 knockout mice
that need further study are cataract and male infertility [29].
4. Inactivation of Pex11α and β
In contrast to the other knocked out peroxins, Pex11 proteins,
encoded by three different genes in mammals, do not have a
function in the import of peroxisomal matrix proteins [31]. They
are peroxisomal membrane proteins that seem to be involved in
the division of peroxisomes since overexpression of Pex11β
leads to peroxisome proliferation whereas inactivation causes
reduced peroxisome abundance [32,33]. Pex11αp seems to be
responsible for peroxisome proliferation in response to external
stimuli whereas Pex11βp is required for constitutive peroxisome
biogenesis [31]. A recently reported function of Pex11βp is to
recruit the dynamin like protein DLP1 to the peroxisomal
membrane [34].
Pex11α knockout mice did not have an obvious phenotype
suggesting that its function can be taken over by other Pex11
proteins [35]. In tissues of Pex11β knockout mice only minor
metabolic alterations were found i.e. a 20% depletion of plasma-
logen levels in brain and a 1.4-fold elevation of C26:0 in liver
[36]. Moreover, studies in fibroblasts documented normal
import of PTS1 and PTS2 containing proteins. It was therefore
unexpected that the phenotype of Pex11β deficient mice was
very similar to that of Pex5, Pex2 and Pex13 knockout mice [36]
i.e. these mice were all very hypotonic and growth retarded at
birth, they displayed a neuronal migration defect and died in the
postnatal period. However, no alterations of mitochondrial
structure in hepatocytes were noted. Although it could be
envisaged that the migration defect and hypotonia are caused by
metabolic abnormalities different from peroxisomal β-oxidation
or ether phospholipid synthesis defects, it seems inexplicable
that such a severe phenotype is present despite intact import of
PTS1 and PTS2 proteins. In order to reconcile these discre-
pancies an alternative model of pathogenesis was proposed in
which the disease phenotype correlates with the abundance and
distribution of peroxisomes rather than with their metabolic
activity [7]. Indeed, Pex11β deficient fibroblasts and hepato-cytes have a reduced peroxisome abundance and increased
clustering and elongation of peroxisomes in common with
Pex13 knockout fibroblasts and neurons [7]. For Pex13
knockout fibroblasts and neurons it was shown that the remnant
peroxisomes were associated only with centrally located micro-
tubuli, and they were apparently not able to travel to the cell
periphery (see also 2.1). It is not unlikely that the abnormal
distribution of peroxisomes on these microtubuli hinders the
dynamic activity of the cytoskeleton which is necessary for
normal migration to occur [37,38].
5. Conditional Pex5 KO mice
Because of their early postnatal death, the generalised Pex2,
Pex5 and Pex13 knockout mice do not allow to study the
functional importance of peroxisomes in adult tissues. Fortu-
nately, thanks to a second wave of technological developments a
gene can now be conditionally inactivated in the mouse. The
technique is based on the use of two mouse lines, one in which
two LoxP sites are introduced by homologous recombination in
introns flanking an essential part of the gene of interest and
another line expressing Cre recombinase. In the presence of Cre
recombinase, the gene fragment encompassed by the two loxP
sites will be deleted, given that these sites have the same
orientation [39]. By mating the loxP containing mice with mice
expressing Cre recombinase under the control of a cell type
specific promotor, the target gene will be inactivated from the
moment that the promotor driving Cre expression becomes
active in the target cells. At this point two mouse lines with
floxed Pex genes are available i.e. Pex5-loxP [40] and Pex13-
loxP mice [41].
5.1. Mice with selective inactivation of peroxisomes in
hepatocytes in the postnatal period
As already mentioned, the only defect observed in liver of
newborn Pex2, Pex5 and Pex13 knockout mice was a change in
the ultrastructure of the mitochondrial inner membrane. In order
to investigate hepatic changes developing at later ages, Pex5-
loxPmice were bred with mice expressing Cre under the control
of the albumin promotor [42]. The resulting mice with hepa-
tocyte specific elimination of peroxisomes will be denoted
further as L-Pex5 knockout mice [43].
Functional peroxisomes were eliminated from the liver
between the first and second postnatal week, as shown by a
number of biochemical parameters. Electronmicroscopic anal-
ysis of 10-week-old mice further confirmed the virtual absence
of catalase containing peroxisomes from hepatocytes but not
from endothelial cells and Kuppfer cells [43]. Only a few small
clusters of hepatocytes with catalase-positive peroxisomes were
found. Surprisingly, plasmalogen and C26:0 levels were normal
in the peroxisome deficient livers suggesting that peroxisomes
present in other tissues provided precursors for plasmalogens
and degraded C26:0. Other parameters i.e. the concentration of
branched chain fatty acids phytanic acid and pristanic acid and
the ratio of C27/C24 bile acids were increased in L-Pex5 knock-
out livers, as expected.
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also occurred in L-Pex5 knockout mice. First, they displayed a
severe hepatomegaly which was due to hypertrophic and
hyperplastic hepatocytes, particularly in the pericentral region
(Fig. 2A, B). Furthermore, fibrosis developed in these livers
from the age of 20 weeks on (Fig. 2C, D). Throughout the
lifetime of the mice (>15 months), they looked healthy, were
fertile and hepatocellular integrity was unaffected as judged by
normal plasma values of alanine and aspartate aminotransferase.
However, all the L-Pex5 knockout mice developed extensive
liver tumours from 12 months on [43].
Severe changes in mitochondrial ultrastructure were ob-
served in 60–70% of the mitochondria in peroxisome deficient
hepatocytes. The most common finding was the proliferation of
pleomorphic mitochondria with rarefication of cristae or with
abnormally curled or stacked cristae. Strikingly, mitochondria
were normal in the few hepatocytes in which catalase-positive
peroxisomes were present, indicating that this is a cell autono-
mous phenomenon. Additional ultrastructural changes in
hepatocytes lacking perixosomes were the proliferation of
smooth endoplasmic reticulum (sER) and the appearance of
lipid droplets and large groups of lysosomes with electron-dense
deposits around dilated bile canaliculi. The ER proliferation
was associated with the induction of the cytochrome P450
ω-hydroxylation enzyme CYP4A1 [43].
Analyses of mitochondrial functions demonstrated that the
complexes I, III and Vof the respiratory chain that are embedded
in the inner membrane were severely inactivated whereas several
matrix enzymes including citrate synthase and mitochondrial
β-oxidation were induced. Given the importance of the com-
plexes to generate ATP, it was surprising that no significant
depletion of ATP levels were found [43]. However, a compen-
satory increase in glycolysis as an alternative source of ATP was
demonstrated. Another consequence of the impaired functioning
of the respiratory chain was a collapse of the inner mitochondrial
membrane potential (Fig. 2E, F). Because dysfunction of the
electron transport chain is often accompanied by the generation
of oxygen radicals that in turn can cause mitochondrial damage,
the hypothesis that reactive oxygen species were increased in the
peroxisome deficient livers was investigated. However, neither
oxidative damage to proteins or lipids, nor increased peroxide
production in cultured hepatocytes or elevation of oxidative
stress defence mechanisms were found, indicating that the
mitochondrial alterations were not related to an excessive pro-
duction of oxidative radicals [43].
Altogether, it can be concluded that peroxisomes are essential
for the maintenance of other subcellular compartments in adult
hepatocytes although their absence is not detrimental for the
functioning of the cell. The molecular interrelationship between
peroxisomes and mitochondria remains to be investigated.
5.2. Mice with selective inactivation of peroxisomes in Sertoli
cells
In view of the early postnatal death of patients with pero-
xisome biogenesis disorders, not much is known about the
importance of peroxisomes for testicular function and fertility.Testicular abnormalities were reported in patients with other
peroxisomal diseases with longer survival such as X-linked
adrenoleukodystrophy [44,45] or X-linked adrenomyeloneuro-
pathy [46]. Male infertility was reported in three different mouse
models with single peroxisomal enzyme deficiencies i.e. acyl-
CoA oxidase [47], MFP-2 [48] and DHAPAT [26] knockout
mice. In acyl-CoA oxidase deficient mice a reduction in the
Leydig cell population and hypospermatogenesis were seen
whereas inDHAPAT knockout mice an arrest of spermatogenesis
before the stage of round spermatids resulting in the complete
absence of spermatozoa was described. In contrast, infertility in
MFP-2 knockout mice [48] was associated with the accumula-
tion of huge lipid droplets in Sertoli cells followed by a complete
fatty degeneration of the tubuli seminiferi while Leydig cell
function was preserved. In fact, until recently it was thought that
peroxisomes were present only in the interstitial cells of Leydig
but according to new data [48,49] they occur also in sperma-
togonia and in Sertoli cells, both located in the basal compart-
ment of the seminiferous epithelium.
The Cre-loxP technology was recently applied to demon-
strate the crucial role of peroxisomes in Sertoli cells. Therefore,
Pex5-loxP mice were bred with mice expressing Cre under the
control of the Anti-Mullerian hormone (AMH) promoter
[48,50]. In the testis extensive accumulations of neutral lipids
were observed in Sertoli cells (Fig. 2G, H), beginning in pre-
pubertal mice and evolving in complete testicular atrophy by the
age of 4 months. Spermatogenesis was already severely affected
at the age of 7 weeks and pre- and postmeiotic germ cells
gradually disappeared from the tubuli seminiferi. The AMH-
Pex5 knockout mice were completely infertile. Together with
analogous Sertoli cell abnormalities in MFP-2 knockout mice
[48], these data strongly indicate that peroxisomalβ-oxidation is
essential to maintain the lipid balance in Sertoli cells which in
turn is crucial for male fertility. It needs to be further investigated
how the fatty degeneration of the testis relates to the loss of
peroxisomal function in Sertoli cells.
6. Conclusions
The phenotypic analyses of mouse models with peroxisome
biogenesis disorders have taught us that several but not all
changes overlap with those occurring in human diseases. The
discrepancies may relate to the huge time difference in develop-
mental period between mice and men and to differences in
dietary composition.
In order to understand the importance of peroxisomes for the
functioning of different tissues, these animal models still need to
be investigated in more detail, including gene expression and
more extensive lipidomic analyses. The latter will require
sensitive techniques because several of the substrates or reaction
products of the peroxisomal pathways are present in very low
amounts. It will be further instrumental to compare the metabolic
and histological abnormalities of the Pex knockouts with those
of single peroxisomal enzyme or transporter knockouts that are
already available or being generated (Acox1 [47], MFP-1[51],
MFP-2 [48,52,53], SCPx [54], phytanoyl-CoA hydroxylase, α-
methylacyl-CoA racemase [55], DHAPAT [26], ALD [56–58],
Fig. 2. Pathology in tissue selective Pex5 knockout mice. (A–B) Hematoxylin–eosin staining of livers of 10-week-old control (A) and L-Pex5 knockout mice (B)
reveals hypertrophic and hyperplastic hepatocytes in the knockout, in particular in the pericentral region. (C–D) Sirius red stains collagen fibers in 20-week-old L-Pex5
knockout mice (D), compatible with fibrosis, but not in control mice (C). (E–F) Hepatocyte cultures were incubated with the mitotracker JC-1. Mitochondria from
control mice (E) fluoresce orange corresponding with a normal inner mitochondrial membrane potential whereas those of L-Pex5 knockout mice fluoresce green
indicative of a reduced potential, n=nucleus. (G–H)Oil redO stains neutral lipid droplets in the outer layer of tubuli seminiferi of 9-week-oldAMH-Pex5 knockoutmice
(H) (arrowheads) but not in control mice (G). This is compatible with a Sertoli cell localisation. Leydig cells (arrows) stain in both genotypes because of their high steroid
content. (A–F) Reprinted from [43] with permission from the publisher.
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served changes are not related to metabolic disturbances but to
an altered distribution of peroxisomes or peroxisomal remnants
will also need to be further substantiated.
Finally, the breeding of Pex-loxP mice with appropriate Cre
expressing mice may reveal more unsuspected roles of peroxi-
somes in certain cell types as already exemplified by the Sertoli
cell selective inactivation of Pex5.
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